Talent Partners, GP, a portfolio company of Abry Partners, has completed a leveraged dividend recapitalization transaction

2015-12-22T05:00:00.0000000 /-/media/assets/images/transactions/2017/talent-partners.png /about-us/transactions/solvency-opinion/solvency-opinion---talent-partners-gp case study {D59CA77E-C551-45A3-BE89-F567210C5A60} {0F018BB9-D33D-48CA-8D10-C8A862F6AF72} {13E28841-C245-441D-8C3B-49E72DA5381C} {E010DCD9-B7BA-4B98-9F3C-A51506B5C1D8} {D3AE3EC6-3254-4441-B111-1AF8D558906C}

Other Areas We Can Help

Corporate Finance

Corporate Finance

Comprehensive support throughout mergers and acquisitions and other corporate transactions.

Corporate Finance

Solvency Opinions

Comprehensive advisory on solvency matters, including dividends, distributions and other transfers.

Solvency Opinions

Financial Sponsors Group

Dedicated coverage and access to M&A deal-flow for financial sponsors.

Financial Sponsors Group
Valuation Services

Valuation Services

Objective valuations for financial reporting, tax and management planning purposes.

Valuation Services

Transaction Advisory Services

Seamless analytical advisory through the deal continuum, from transaction origination to closing.

Transaction Advisory Services

Related Case Studies

Financial and Operational Restructuring

Duff & Phelps Advised Cristian Lay on its acquisition of Grupo Gallardo to KKR

Duff & Phelps Advised Cristian Lay on its acquisition of Grupo Gallardo to KKR on the standstill agreement between all lenders, assist with cash management, financial due diligence and operational due diligence.

Duff & Phelps Advised Cristian Lay on its acquisition of Grupo Gallardo to KKR

Insights

Valuation Insights

U.S. Security and Exchange Commission’s Fund Valuation Modernization Proposal

Valuation Insights
Valuation Insights

Highlights from the Dow Jones Industrial Average Special Report

Valuation Insights
Valuation Insights

Global Enforcement of Anti-Money Laundering Regulations

Valuation Insights
Valuation Insights

Reshoring Pharmaceutical and Medical Device Supply Chains: A New Tipping Point?

Valuation Insights

News

Events